Researchers sought to evaluate differences in ctDNA profiles, use of targeted treatments, and overall survival between Black and White patients with metastatic breast cancer.

The FDA has approved Stoboclo (denosumab-bmwo), a biosimilar to Prolia (denosumab), and Osenvelt (denosumab-bmwo), a biosimilar to Xgeva (denosumab).

This is a public health crisis that exacerbates overdiagnosis and threatens the sustainability of health systems,” said Ray Moynihan, PhD.

Researchers evaluated links between lifestyle and dietary index scores and risk of death in a prospective, multiethnic cohort of men diagnosed with non-metastatic prostate cancer.

Researchers are projecting that, worldwide, new cases of female breast cancer will increase 38% by 2050, and female breast cancer deaths will increase 68%. These projections and other data were ...